Latest Healthcare It News

Resmed delivered a strong FY2026 with 10% revenue growth to $5.7 billion, a 17% rise in non-GAAP EPS, and a 10% dividend hike. Strategic moves include selling MatrixCare and acquiring Noctrix Health.

Wellnex Life has agreed to sell its Pain Away brand to Mentholatum Australasia for up to A$21.3 million, aiming to wipe out debt and sharpen its strategic focus.

Argent BioPharma's licensing partner Splash Beverage Group has launched the US veterinary development program for CannEpil®, targeting companion-animal oncology and chronic pain. Led by industry veteran Dr Hunter Land, the initiative follows a defined FDA regulatory pathway and could broaden CannEpil®’s commercial footprint beyond human neurology.

Integral Diagnostics has installed Jason Martinez as its new CEO, marking a leadership change as the company prepares to present its FY26 results. Martinez brings over 20 years of diagnostic imaging experience and aims to drive growth and innovation following the retirement of long-serving CEO Ian Kadish.

Kinatico Limited reports a robust FY26 with SaaS revenue growth driving total revenue up 9.4% to $35.2 million and net profit after tax soaring 78.5% to $2.0 million, underpinned by its AI-native compliance platform.

Promisia Healthcare is set to acquire Chatswood Retirement Village in Christchurch for $25 million, bolstering its East Christchurch presence and promising immediate earnings accretion.

Lumos Diagnostics has landed a US$767,800 purchase order for its FebriDx rapid test from PHASE Scientific, marking a key step in commercialising its FDA-approved product ahead of the US flu season.

Charter Hall Social Infrastructure REIT (ASX:CQE) reported a 13.1% rise in operating earnings per unit for FY26, driven by strategic acquisitions and strong rental growth, while raising guidance for FY27.

Stakk Ltd's combined pro forma FY2026 revenue with ParaScript has climbed to approximately A$45 million, surpassing earlier forecasts by 9%. Both companies outperformed initial revenue assumptions, setting a stronger baseline ahead of integration benefits.

Control Bionics has achieved FDA registration for its NeuroStrip surface EMG platform, cementing its medical device status in the US and bolstering its appeal in clinical and research markets.

Regis Healthcare is set to acquire Royal Freemasons Homes of Victoria’s home care business, adding around 480 clients and lifting its annual home care revenue to approximately $50 million. The deal, funded from existing cash, awaits regulatory approval and is expected to close in the second quarter of FY27.

Talius Group has secured a $1.65 million three-year deal to deploy its Talius One platform across three Queensland aged care facilities, boosting annual recurring revenue by $134,602 and deepening its relationship with Adventist Retirement Plus.